EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso

NCT03095339 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2018-04-03

No results posted yet for this study

Summary

This is a pre-post randomized community-based controlled trial aimed at estimating the effectiveness of an educational package developed using PRECEDE PROCEED to reduce the cumulative incidence of Taenia solium cysticercosis in three Provinces of Burkina Faso. The study design included an 18-months baseline study to measure baseline cumulative incidence of cysticercosis followed by an 18-month post randomization study to measure the effectiveness of the intervention. Sixty villages of three Provinces of Burkina Faso were included. The primary outcome was the change in the baseline to post randomization cumulative incidence in the intervention group compared to the control group.

Conditions

  • Cysticercosis

Interventions

OTHER

Educational package

The educational package was offered to 30 villages post randomization. The field team completed the SARAR PHAST with community members for 2-3 days in each intervention village. The movie was projected every night for 2-3 days in each intervention village.

Sponsors & Collaborators

  • AFRICSanté

    collaborator OTHER
  • Institute of Tropical Medicine, Belgium

    collaborator OTHER
  • Institut de Recherche en Sciences de la Sante, Burkina Faso

    collaborator OTHER_GOV
  • University of Ouagadougou, Burkina Faso

    collaborator OTHER
  • University Hospital, Limoges

    collaborator OTHER
  • Centre Universitaire Souro Sanou

    collaborator UNKNOWN
  • Technical University of Munich

    collaborator OTHER
  • Brown University

    collaborator OTHER
  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Hélène Carabin, DVM PhD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-21
Primary Completion
2014-11-24
Completion
2015-01-31

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03095339 on ClinicalTrials.gov